北陆药业：关于获得枸橼酸西地那非口崩片《药品注册证书》的公告

Core Viewpoint - Beilu Pharmaceutical has received approval from the National Medical Products Administration for the registration of its oral disintegrating tablet formulation of Sildenafil Citrate [2] Group 1 - The approval signifies a significant milestone for Beilu Pharmaceutical in expanding its product portfolio [2] - Sildenafil Citrate is commonly used for the treatment of erectile dysfunction, indicating potential market demand [2] - The issuance of the drug registration certificate is a crucial step towards commercialization and market entry [2]